Brief: Alligator Bioscience, Aptevo Therapeutics Announce FDA Issues "May Proceed" Notification

Aptevo Therapeutics

19/09/2022 13:52

Sept 19 (Reuters) - Alligator Bioscience AB  ATORX.ST :
    * ALLIGATOR BIOSCIENCE AND APTEVO THERAPEUTICS ANNOUNCE THAT
FDA
HAS ISSUED A “MAY PROCEED” NOTIFICATION FOR THE ALG.APV-527 IND

Source text for Eikon:  ID:nMFNbkQzjS 
Further company coverage:  APVO.O 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))